7 Products Boston Scientific is Betting on in 2014: Lotus Transcatheter Aortic Valve Replacement System

Lotus Transcatheter Aortic Valve Replacement System Boston Scientific received CE Mark approval and initiated sales for the Lotus Valve System, a second-generation TAVR technology, in Q4 2013. “Impressions from the commercial accounts we have launched into thus far has been very positive,” Mahoney said. The company will expand roll-out of the product in international markets and initiate an IDE trial in the United States this year.

WatchmanVessix 

 

 

 

[image courtesy of BOSTON SCIENTIFIC]

Filed Under
500 characters remaining